Boxborough, MA, United States of America

Jeevanandam Arumugasamy

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Sumitomo Dainippon Pharma Oncology, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeevanandam Arumugasamy. Retrieved from https://idiyas.com/inventor/jeevanandam-arumugasamy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jeevanandam Arumugasamy

Introduction

Jeevanandam Arumugasamy is an accomplished inventor based in Boxborough, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on naphthofuran derivatives.

Latest Patents

Arumugasamy holds 1 patent for his invention titled "Naphthofuran derivatives, preparation, and methods of use thereof." This patent details methods of preparation by reacting specific compounds with acid, where the components are defined by their respective leaving groups. The patent also claims intermediates necessary for the synthesis of these derivatives.

Career Highlights

Throughout his career, Arumugasamy has worked with notable companies in the pharmaceutical industry, including Sumitomo Dainippon Pharma Oncology, Inc. and Idenix Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Arumugasamy has collaborated with esteemed colleagues such as Wei Li and Adel M Moussa, contributing to a dynamic exchange of ideas and advancements in their field.

Conclusion

Jeevanandam Arumugasamy's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research and development in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…